Halozyme Therapeutics, Inc. (HALO)
USD 60.13
(4.21%)
USD 60.13
(4.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.64 Billion USD | -1.33% |
| 2022 | 1.67 Billion USD | 84.22% |
| 2021 | 907.47 Million USD | 111.59% |
| 2020 | 428.87 Million USD | -9.54% |
| 2019 | 474.1 Million USD | 147.76% |
| 2018 | 191.36 Million USD | -38.58% |
| 2017 | 311.57 Million USD | 5.98% |
| 2016 | 293.99 Million USD | 111.83% |
| 2015 | 138.79 Million USD | 11.37% |
| 2014 | 124.62 Million USD | 2.33% |
| 2013 | 121.78 Million USD | 41.82% |
| 2012 | 85.87 Million USD | 56.54% |
| 2011 | 54.85 Million USD | -22.73% |
| 2010 | 70.99 Million USD | 1.06% |
| 2009 | 70.24 Million USD | 14.81% |
| 2008 | 61.18 Million USD | 33.9% |
| 2007 | 45.69 Million USD | 98.58% |
| 2006 | 23.01 Million USD | 898.98% |
| 2005 | 2.3 Million USD | 45.84% |
| 2004 | 1.57 Million USD | 4117.05% |
| 2003 | 37.45 Thousand USD | 258.95% |
| 2002 | 10.43 Thousand USD | 217.24% |
| 2001 | 3289.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.68 Billion USD | 0.98% |
| 2024 Q1 | 1.66 Billion USD | 0.86% |
| 2024 Q3 | 1.66 Billion USD | -0.88% |
| 2023 Q2 | 1.65 Billion USD | 1.58% |
| 2023 Q1 | 1.63 Billion USD | -2.28% |
| 2023 Q4 | 1.64 Billion USD | 0.36% |
| 2023 FY | 1.64 Billion USD | -1.33% |
| 2023 Q3 | 1.64 Billion USD | -0.96% |
| 2022 Q1 | 901.99 Million USD | -0.6% |
| 2022 Q3 | 1.76 Billion USD | 18.77% |
| 2022 FY | 1.67 Billion USD | 84.22% |
| 2022 Q2 | 1.48 Billion USD | 64.99% |
| 2022 Q4 | 1.67 Billion USD | -5.42% |
| 2021 Q2 | 906.11 Million USD | 0.79% |
| 2021 Q1 | 898.98 Million USD | 109.61% |
| 2021 Q3 | 903.74 Million USD | -0.26% |
| 2021 Q4 | 907.47 Million USD | 0.41% |
| 2021 FY | 907.47 Million USD | 111.59% |
| 2020 Q3 | 425.04 Million USD | 0.86% |
| 2020 Q4 | 428.87 Million USD | 0.9% |
| 2020 FY | 428.87 Million USD | -9.54% |
| 2020 Q1 | 434.31 Million USD | -8.39% |
| 2020 Q2 | 421.42 Million USD | -2.97% |
| 2019 FY | 474.1 Million USD | 147.76% |
| 2019 Q1 | 169.06 Million USD | -11.65% |
| 2019 Q2 | 157.77 Million USD | -6.67% |
| 2019 Q3 | 125 Million USD | -20.77% |
| 2019 Q4 | 474.1 Million USD | 279.28% |
| 2018 FY | 191.36 Million USD | -38.58% |
| 2018 Q3 | 204.76 Million USD | -6.85% |
| 2018 Q4 | 191.36 Million USD | -6.55% |
| 2018 Q2 | 219.82 Million USD | -4.59% |
| 2018 Q1 | 230.4 Million USD | -26.05% |
| 2017 Q4 | 311.57 Million USD | 9.42% |
| 2017 Q2 | 286.62 Million USD | 0.47% |
| 2017 Q1 | 285.26 Million USD | -2.97% |
| 2017 Q3 | 284.76 Million USD | -0.65% |
| 2017 FY | 311.57 Million USD | 5.98% |
| 2016 Q4 | 293.99 Million USD | -0.17% |
| 2016 FY | 293.99 Million USD | 111.83% |
| 2016 Q2 | 286.2 Million USD | 2.35% |
| 2016 Q3 | 294.49 Million USD | 2.89% |
| 2016 Q1 | 279.62 Million USD | 101.47% |
| 2015 Q2 | 123.81 Million USD | 1.84% |
| 2015 FY | 138.79 Million USD | 11.37% |
| 2015 Q1 | 121.58 Million USD | -2.44% |
| 2015 Q4 | 138.79 Million USD | 9.34% |
| 2015 Q3 | 126.93 Million USD | 2.52% |
| 2014 Q4 | 124.62 Million USD | -0.05% |
| 2014 Q3 | 124.68 Million USD | -1.63% |
| 2014 Q2 | 126.75 Million USD | -3.2% |
| 2014 Q1 | 130.93 Million USD | 7.52% |
| 2014 FY | 124.62 Million USD | 2.33% |
| 2013 Q4 | 121.78 Million USD | 7.17% |
| 2013 Q3 | 113.63 Million USD | 18.07% |
| 2013 Q2 | 96.24 Million USD | 12.98% |
| 2013 Q1 | 85.18 Million USD | -0.8% |
| 2013 FY | 121.78 Million USD | 41.82% |
| 2012 Q2 | 52.51 Million USD | -2.13% |
| 2012 FY | 85.87 Million USD | 56.54% |
| 2012 Q3 | 56.79 Million USD | 8.15% |
| 2012 Q4 | 85.87 Million USD | 51.21% |
| 2012 Q1 | 53.65 Million USD | -2.19% |
| 2011 Q1 | 67.41 Million USD | -5.04% |
| 2011 Q4 | 54.85 Million USD | 7.17% |
| 2011 FY | 54.85 Million USD | -22.73% |
| 2011 Q3 | 51.18 Million USD | -26.3% |
| 2011 Q2 | 69.45 Million USD | 3.02% |
| 2010 Q4 | 70.99 Million USD | 8.57% |
| 2010 Q2 | 65.6 Million USD | -4.03% |
| 2010 Q3 | 65.38 Million USD | -0.33% |
| 2010 Q1 | 68.35 Million USD | -2.69% |
| 2010 FY | 70.99 Million USD | 1.06% |
| 2009 Q3 | 69.5 Million USD | -0.5% |
| 2009 FY | 70.24 Million USD | 14.81% |
| 2009 Q4 | 70.24 Million USD | 1.06% |
| 2009 Q2 | 69.86 Million USD | 7.47% |
| 2009 Q1 | 65 Million USD | 6.24% |
| 2008 Q4 | 61.18 Million USD | 22.69% |
| 2008 FY | 61.18 Million USD | 33.9% |
| 2008 Q1 | 49.6 Million USD | 8.55% |
| 2008 Q2 | 48.9 Million USD | -1.41% |
| 2008 Q3 | 49.86 Million USD | 1.97% |
| 2007 Q1 | 32.96 Million USD | 43.25% |
| 2007 FY | 45.69 Million USD | 98.58% |
| 2007 Q4 | 45.69 Million USD | 1.36% |
| 2007 Q3 | 45.07 Million USD | 35.08% |
| 2007 Q2 | 33.37 Million USD | 1.24% |
| 2006 Q1 | 2.69 Million USD | 16.93% |
| 2006 Q3 | 2.75 Million USD | 13.66% |
| 2006 Q4 | 23.01 Million USD | 734.59% |
| 2006 FY | 23.01 Million USD | 898.98% |
| 2006 Q2 | 2.42 Million USD | -9.93% |
| 2005 Q1 | 1.92 Million USD | 22.07% |
| 2005 Q4 | 2.3 Million USD | 27.15% |
| 2005 FY | 2.3 Million USD | 45.84% |
| 2005 Q3 | 1.81 Million USD | 5.6% |
| 2005 Q2 | 1.71 Million USD | -11.02% |
| 2004 Q2 | 1.29 Million USD | 67.31% |
| 2004 Q4 | 1.57 Million USD | -20.69% |
| 2004 Q3 | 1.99 Million USD | 53.93% |
| 2004 Q1 | 773.24 Thousand USD | 1964.57% |
| 2004 FY | 1.57 Million USD | 4117.05% |
| 2003 Q3 | 4752.00 USD | 0.0% |
| 2003 Q2 | 4752.00 USD | -67.11% |
| 2003 Q4 | 37.45 Thousand USD | 688.15% |
| 2003 Q1 | 14.44 Thousand USD | 38.45% |
| 2003 FY | 37.45 Thousand USD | 258.95% |
| 2002 Q3 | 4625.00 USD | 39.1% |
| 2002 Q4 | 10.43 Thousand USD | 125.6% |
| 2002 Q1 | 5082.00 USD | 0.0% |
| 2002 Q2 | 3325.00 USD | -34.57% |
| 2002 FY | 10.43 Thousand USD | 217.24% |
| 2001 FY | 3289.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 72.56 Million USD | -2173.019% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -46643.852% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -84228.323% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -4198.496% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -238.976% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1165.536% |
| Agenus Inc. | 462.29 Million USD | -256.799% |
| Fortress Biotech, Inc. | 165.93 Million USD | -894.017% |
| GlycoMimetics, Inc. | 6.9 Million USD | -23798.063% |
| Novavax, Inc. | 2.57 Billion USD | 35.875% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4262.271% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -10042.421% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3361.62% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -627.173% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -505.781% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 59.278% |
| AlloVir, Inc. | 45.01 Million USD | -3564.25% |
| Aptorum Group Limited | 5.25 Million USD | -31278.052% |
| Ardelyx, Inc. | 130.76 Million USD | -1161.413% |
| Bicycle Therapeutics plc | 224.41 Million USD | -635.015% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1166.771% |
| Chimerix, Inc. | 19.74 Million USD | -8253.821% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -4589.02% |
| CRISPR Therapeutics AG | 346.76 Million USD | -375.667% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3203.549% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1070.495% |
| Dyadic International, Inc. | 2.34 Million USD | -70370.224% |
| Elevation Oncology, Inc. | 34.28 Million USD | -4711.452% |
| Fortress Biotech, Inc. | 165.93 Million USD | -894.017% |
| GT Biopharma, Inc. | 6.63 Million USD | -24767.511% |
| Alkermes plc | 933.53 Million USD | -76.69% |
| Immix Biopharma, Inc. | 3.72 Million USD | -44219.134% |
| Innoviva, Inc. | 568.55 Million USD | -190.116% |
| IO Biotech, Inc. | 17.55 Million USD | -9295.432% |
| Jaguar Health, Inc. | 45.86 Million USD | -3496.263% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1161.954% |
| ContextLogic Inc. | 206 Million USD | -700.71% |
| AbCellera Biologics Inc. | 335.77 Million USD | -391.239% |
| Lantern Pharma Inc. | 2.73 Million USD | -60106.331% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -67362.658% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -244.794% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -601.26% |
| MEI Pharma, Inc. | 8.35 Million USD | -19642.214% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -5895.645% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -24864.316% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -970.086% |
| NextCure, Inc. | 14.99 Million USD | -10898.613% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2207.585% |
| ChromaDex Corporation | 26.5 Million USD | -6122.506% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -5743.768% |
| Incyte Corporation | 1.59 Billion USD | -3.592% |
| Opthea Limited | 264.6 Million USD | -523.376% |
| MiMedx Group, Inc. | 96.33 Million USD | -1612.304% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3429.091% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -5957.962% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -13526.625% |
| Vaxcyte, Inc. | 167.44 Million USD | -885.053% |
| PDS Biotechnology Corporation | 33.25 Million USD | -4859.426% |
| Pharming Group N.V. | 244.07 Million USD | -575.807% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -13735.447% |
| Onconetix, Inc. | 23.18 Million USD | -7015.612% |
| Acelyrin, Inc. | 86.35 Million USD | -1810.139% |
| PureTech Health plc | 125.58 Million USD | -1213.444% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3334.805% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1190.75% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -46641.706% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -24864.316% |
| ESSA Pharma Inc. | 3.49 Million USD | -47093.948% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1030.783% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -40708.065% |
| Seer, Inc. | 39.36 Million USD | -4090.174% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1900.973% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -11371.326% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -24730.077% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -126855.815% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1216.862% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -17301.224% |
| Senti Biosciences, Inc. | 52.57 Million USD | -3037.589% |
| ImmuCell Corporation | 18.81 Million USD | -8666.728% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -988.668% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -4474.469% |
| Precigen, Inc. | 41.64 Million USD | -3860.864% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -16776.018% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -24603.639% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2298.276% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -374.556% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -123403.029% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -233.556% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2567.565% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -17509.288% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -18329.743% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -5584.86% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -625.214% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1096.997% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -15013.267% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -523.875% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1863.038% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -5971.118% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -51033.852% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2136.043% |
| Aptose Biosciences Inc. | 15.8 Million USD | -10333.887% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -14841.204% |
| Soligenix, Inc. | 7.27 Million USD | -22573.316% |
| Century Therapeutics, Inc. | 175.94 Million USD | -837.509% |
| Kura Oncology, Inc. | 51.66 Million USD | -3092.795% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1260.022% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -39809.557% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -24839.494% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -552.999% |
| Autolus Therapeutics plc | 263.9 Million USD | -525.016% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -15636.138% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1756.227% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3417.052% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -367.46% |
| GRI Bio, Inc. | 2.69 Million USD | -61059.14% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -203641.67% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -5205.272% |
| IGM Biosciences, Inc. | 220.17 Million USD | -649.153% |
| INmune Bio, Inc. | 18.86 Million USD | -8644.894% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -543.118% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6091.253% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -60577.544% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -50184.398% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -2721.764% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1615.349% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -523.062% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -100.414% |
| Verastem, Inc. | 71.18 Million USD | -2217.148% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3254.201% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -4175.655% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3270.927% |
| Histogen Inc. | 5.69 Million USD | -28853.168% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -37510.82% |
| Surrozen, Inc. | 8.14 Million USD | -20151.222% |
| Organovo Holdings, Inc. | 2.74 Million USD | -59924.09% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -525444.036% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2833.425% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -9889.474% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -3127.72% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -199381.421% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1201.607% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -15153.602% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -993.163% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -63162.131% |
| Apollomics, Inc. | 14.15 Million USD | -11554.504% |
| Amarin Corporation plc | 279.58 Million USD | -489.964% |
| Mesoblast Limited | 188.79 Million USD | -773.665% |
| Turnstone Biologics Corp. | 14.14 Million USD | -11558.623% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -812.374% |
| Synaptogenix, Inc. | 5.52 Million USD | -29730.387% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -24711.402% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -869.656% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -19175.737% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -93758.46% |
| Exelixis, Inc. | 678.44 Million USD | -143.124% |
| Better Therapeutics, Inc. | 23.84 Million USD | -6818.304% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -905.487% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -177.59% |
| NLS Pharmaceutics AG | 10.68 Million USD | -15344.106% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -101491.879% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -4137.321% |
| Gritstone bio, Inc. | 125.91 Million USD | -1209.939% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -11139.18% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -32314.677% |
| Avid Bioservices, Inc. | 275.66 Million USD | -498.351% |
| Insmed Incorporated | 1.66 Billion USD | 0.74% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -21338.223% |
| MediWound Ltd. | 27.18 Million USD | -5967.098% |
| OmniAb, Inc. | 87.4 Million USD | -1787.256% |
| Alector, Inc. | 487.66 Million USD | -238.234% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -308.833% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -8852.304% |
| Zai Lab Limited | 240.17 Million USD | -586.769% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -161.795% |
| Aura Biosciences, Inc. | 29.22 Million USD | -5543.624% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1634.87% |
| Immunic, Inc. | 25.36 Million USD | -6402.137% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2282.376% |
| Veracyte, Inc. | 93.71 Million USD | -1660.008% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -62936.612% |
| FibroGen, Inc. | 585.72 Million USD | -181.609% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9388.937% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -252468.154% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -29065.843% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 78.456% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -20020.298% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1863.131% |
| TG Therapeutics, Inc. | 169.08 Million USD | -875.522% |
| Galecto, Inc. | 5.89 Million USD | -27875.95% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -19811.42% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 37.005% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -5622.927% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -12969.186% |
| XBiotech Inc. | 8.39 Million USD | -19543.468% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -11139.18% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -3001.659% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -354.265% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -6035.478% |
| Theravance Biopharma, Inc. | 169 Million USD | -875.99% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -35.691% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -229.612% |
| Vaxxinity, Inc. | 30.94 Million USD | -5230.474% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -69.613% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -27249.241% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -121.335% |
| NexImmune, Inc. | 5.08 Million USD | -32342.697% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -444027.261% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -53543.692% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 76.791% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -31903.345% |
| Scopus BioPharma Inc. | 7.45 Million USD | -22027.26% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -6173.15% |
| Ainos, Inc. | 7.39 Million USD | -22207.442% |
| Pluri Inc. | 34.11 Million USD | -4735.43% |
| Prothena Corporation plc | 135.01 Million USD | -1121.67% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -578.503% |
| Celularity Inc. | 102.92 Million USD | -1502.524% |
| Rallybio Corporation | 9.43 Million USD | -17380.521% |
| Cue Biopharma, Inc. | 24.44 Million USD | -6647.646% |
| MeiraGTx Holdings plc | 319.99 Million USD | -415.471% |
| Omeros Corporation | 403.25 Million USD | -309.04% |
| Humacyte, Inc. | 114.67 Million USD | -1338.355% |
| Immunocore Holdings plc | 228.15 Million USD | -622.947% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -33735.118% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -2049.416% |
| Blueprint Medicines Corporation | 918.64 Million USD | -79.555% |
| CalciMedica, Inc. | 4.02 Million USD | -40849.901% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -9351.421% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1822.069% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -493.774% |
| Pulmatrix, Inc. | 15.96 Million USD | -10233.033% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -10357.503% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -6603.495% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -557.659% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -3147.867% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -36.247% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -5089.762% |
| Nutriband Inc. | 1.07 Million USD | -152780.986% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -15412.668% |
| Vor Biopharma Inc. | 59.1 Million USD | -2690.779% |
| Roivant Sciences Ltd. | 773.95 Million USD | -113.122% |
| Evogene Ltd. | 17.99 Million USD | -9068.772% |
| ProKidney Corp. | 29.21 Million USD | -5545.749% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2191.588% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -233871.883% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 12.677% |
| CorMedix Inc. | 11.91 Million USD | -13740.639% |
| BioLineRx Ltd. | 50.7 Million USD | -3153.248% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1003.622% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1765.042% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3255.156% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -5194.831% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -9083.064% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1223.423% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -29073.364% |
| MediciNova, Inc. | 3.89 Million USD | -42285.701% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -8923.809% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -109554.105% |
| GeoVax Labs, Inc. | 3.51 Million USD | -46761.3% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -315.211% |
| Biomea Fusion, Inc. | 30.69 Million USD | -5274.591% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 39.397% |
| Mereo BioPharma Group plc | 15.96 Million USD | -10233.68% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -5186.568% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -2710.753% |
| Absci Corporation | 58.3 Million USD | -2729.072% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8559.502% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -5044.601% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2135.346% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1785.466% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -4784.4% |
| Allakos Inc. | 74.79 Million USD | -2105.369% |
| Imunon, Inc. | 8.53 Million USD | -19236.218% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -7230.616% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1336.663% |
| BioAtla, Inc. | 48.98 Million USD | -3267.211% |
| NLS Pharmaceutics AG | 10.68 Million USD | -15344.106% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -59254.516% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1162.949% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -11503.672% |
| XOMA Corporation | 145.58 Million USD | -1033.028% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -4799.635% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2298.903% |
| aTyr Pharma, Inc. | 31.59 Million USD | -5120.312% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2568.039% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -3568.324% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3307.839% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -57372.544% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -20118.906% |
| Akari Therapeutics, Plc | 4.58 Million USD | -35883.028% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -9201.584% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -408275.67% |
| UroGen Pharma Ltd. | 243.52 Million USD | -577.333% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -413.712% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -59629.399% |
| Orgenesis Inc. | 35.53 Million USD | -4541.795% |
| Entera Bio Ltd. | 1.37 Million USD | -119512.908% |
| GH Research PLC | 6.7 Million USD | -24515.162% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -24156.794% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -8661.617% |
| Xencor, Inc. | 283.55 Million USD | -481.7% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -55145.866% |
| Replimune Group, Inc. | 113.21 Million USD | -1356.942% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -43802.239% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1493.221% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -408275.67% |
| Portage Biotech Inc. | 4.45 Million USD | -36966.562% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -109554.105% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -7056.017% |
| OncoCyte Corporation | 49.29 Million USD | -3245.9% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -39772.849% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -206733.241% |
| Purple Biotech Ltd. | 10 Million USD | -16386.377% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -28407.812% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2780.603% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -13214.976% |
| HilleVax, Inc. | 78.9 Million USD | -1990.334% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -32562.614% |
| Tharimmune, Inc. | 1.81 Million USD | -90777.146% |
| Genprex, Inc. | 3.25 Million USD | -50587.049% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -5982.311% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -31402.33% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -800609.709% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -459939.381% |
| OKYO Pharma Limited | 7.42 Million USD | -22127.412% |
| Savara Inc. | 37.19 Million USD | -4334.991% |
| Curis, Inc. | 57.61 Million USD | -2763.053% |
| Daré Bioscience, Inc. | 26.32 Million USD | -6164.607% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -4107.833% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -114128.67% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -7822.869% |
| BeiGene, Ltd. | 2.23 Billion USD | 26.157% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -7647.663% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -528.613% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -7653.417% |
| Erasca, Inc. | 78.61 Million USD | -1998.259% |
| bluebird bio, Inc. | 424.62 Million USD | -288.452% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -251629.411% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 12.729% |
| DBV Technologies S.A. | 42.8 Million USD | -3753.883% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -251629.411% |
| Moderna, Inc. | 4.57 Billion USD | 63.923% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -23480.586% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -99505.193% |
| Molecular Templates, Inc. | 31.17 Million USD | -5191.656% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -9562.929% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -180.472% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1224.816% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -5911.816% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -4424.528% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2864.792% |
| MacroGenics, Inc. | 154.2 Million USD | -969.641% |
| RenovoRx, Inc. | 4.46 Million USD | -36833.766% |
| Adicet Bio, Inc. | 37.12 Million USD | -4343.594% |
| Prime Medicine, Inc. | 60.78 Million USD | -2613.824% |
| Aditxt, Inc. | 28.53 Million USD | -5681.184% |
| Adagene Inc. | 45.16 Million USD | -3551.729% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -912712.879% |
| Quantum-Si incorporated | 26.63 Million USD | -6093.767% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -136.46% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -54115.139% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1334.801% |
| SciSparc Ltd. | 1.59 Million USD | -103314.545% |
| Vericel Corporation | 127.7 Million USD | -1191.619% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -29540.493% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1832.402% |
| Generation Bio Co. | 171.63 Million USD | -861.057% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -14181.056% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -3843.157% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -552.74% |
| Invivyd, Inc. | 51.71 Million USD | -3089.647% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1693.342% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -25255.855% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -2084.834% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -161453.575% |
| 2seventy bio, Inc. | 310.12 Million USD | -431.868% |
| ADMA Biologics, Inc. | 193.97 Million USD | -750.343% |
| Clene Inc. | 38.95 Million USD | -4134.71% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -4464.992% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -541.874% |
| GeoVax Labs, Inc. | 3.51 Million USD | -46761.3% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -766.938% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -13442.757% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -731.709% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -13425.945% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3328.451% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -3021.557% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -345.977% |
| Evaxion Biotech A/S | 17.61 Million USD | -9262.644% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -924.963% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -976.771% |
| Trevena, Inc. | 48.26 Million USD | -3317.724% |
| Surrozen, Inc. | 8.14 Million USD | -20151.222% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -7538.166% |
| Cingulate Inc. | 10.36 Million USD | -15820.119% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -59880.436% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4323.099% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -45890.598% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -12443.437% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -420.005% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -6537.941% |
| Clearmind Medicine Inc. | 3.61 Million USD | -45591.367% |
| Kronos Bio, Inc. | 54.2 Million USD | -2943.232% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3406.286% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -7147.282% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -8118.136% |
| Statera Biopharma, Inc. | 22.67 Million USD | -7173.898% |
| ImmunityBio, Inc. | 1.09 Billion USD | -51.273% |
| Korro Bio, Inc. | 51.75 Million USD | -3087.243% |
| Kineta, Inc. | 7.22 Million USD | -22739.407% |
| BioVie Inc. | 9.7 Million USD | -16901.03% |
| Codexis, Inc. | 49.94 Million USD | -3202.491% |
| Celularity Inc. | 102.92 Million USD | -1502.524% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1613.78% |
| Celcuity Inc. | 51.45 Million USD | -3105.947% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -477736.231% |
| Cibus, Inc. | 206.11 Million USD | -700.255% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -3783.371% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -6162.432% |
| IN8bio, Inc. | 8.77 Million USD | -18703.716% |
| Kodiak Sciences Inc. | 213.59 Million USD | -672.253% |
| Annexon, Inc. | 47.11 Million USD | -3400.705% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1742.13% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1611.557% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -11949.543% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 36.642% |
| Eyenovia, Inc. | 19.78 Million USD | -8238.921% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -831.447% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -21374.574% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -6744.525% |
| Arcellx, Inc. | 339.75 Million USD | -385.49% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -13763.355% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -571.769% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -17148.374% |
| Moolec Science SA | 13.94 Million USD | -11728.038% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -3722.446% |
| Geron Corporation | 146.12 Million USD | -1028.787% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -3164.193% |
| Royalty Pharma plc | 6.29 Billion USD | 73.808% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -4046.878% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -560167.793% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -66943.615% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -772.011% |
| Humacyte, Inc. | 114.67 Million USD | -1338.355% |
| Structure Therapeutics Inc. | 29.05 Million USD | -5577.814% |
| 89bio, Inc. | 59.96 Million USD | -2650.8% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -6133.088% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -137814.883% |
| Genelux Corporation | 8.42 Million USD | -19489.81% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -23958.664% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1110.002% |
| Notable Labs, Ltd. | 4.42 Million USD | -37159.137% |
| Liquidia Corporation | 73.13 Million USD | -2155.274% |
| Mustang Bio, Inc. | 17.61 Million USD | -9261.837% |
| Immunovant, Inc. | 48.95 Million USD | -3269.343% |
| Quantum-Si incorporated | 26.63 Million USD | -6093.767% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -4197.376% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -53057.009% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2133.197% |
| Acasti Pharma Inc. | 11.55 Million USD | -14172.406% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -7196.009% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -60577.544% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -4372.875% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -120931.051% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -26958.104% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -6541.683% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -7014.657% |
| PepGen Inc. | 34.63 Million USD | -4662.964% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -13482.526% |
| United Therapeutics Corporation | 1.18 Billion USD | -39.525% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -23517.726% |
| Solid Biosciences Inc. | 38.45 Million USD | -4188.996% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -19175.737% |
| Immuneering Corporation | 12 Million USD | -13635.953% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -525444.036% |
| Silo Pharma, Inc. | 1.56 Million USD | -105010.147% |
| Belite Bio, Inc | 4.21 Million USD | -39070.316% |
| XOMA Corporation | 145.58 Million USD | -1033.028% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -67835.008% |
| Bionomics Limited | 10.15 Million USD | -16136.906% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -7575.129% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -7098.804% |
| uniQure N.V. | 624.01 Million USD | -164.329% |
| Cassava Sciences, Inc. | 14.19 Million USD | -11520.021% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -912712.879% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -869.223% |
| Forte Biosciences, Inc. | 3.66 Million USD | -44893.508% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -632889.105% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -24347.34% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -21374.574% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -9388.937% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -15508.081% |
| Altimmune, Inc. | 16.54 Million USD | -9871.961% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -167.03% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -7098.804% |
| Compugen Ltd. | 55.77 Million USD | -2857.35% |
| Peak Bio, Inc. | 20.75 Million USD | -7847.926% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1393.226% |
| Benitec Biopharma Inc. | 4.96 Million USD | -33141.878% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -945.002% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -2094.192% |
| Zura Bio Limited | 21.29 Million USD | -7646.863% |
| PolyPid Ltd. | 17.46 Million USD | -9342.764% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1367.506% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -2094.192% |
| Instil Bio, Inc. | 99.8 Million USD | -1552.751% |
| argenx SE | 444.95 Million USD | -270.706% |
| Immunome, Inc. | 28.65 Million USD | -5655.677% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -19684.839% |
| Verona Pharma plc | 58.84 Million USD | -2703.253% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -11296.822% |
| Shattuck Labs, Inc. | 14.85 Million USD | -11000.76% |
| CervoMed Inc. | 2.59 Million USD | -63444.791% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -33742.06% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -12851.178% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -15556.972% |
| Moolec Science SA | 13.94 Million USD | -11728.038% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -70284.433% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2866.909% |
| AnaptysBio, Inc. | 364.28 Million USD | -352.793% |
| Design Therapeutics, Inc. | 11.95 Million USD | -13696.102% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -12904.273% |
| NeurAxis, Inc. | 1.91 Million USD | -86135.602% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -4137.212% |
| Lumos Pharma, Inc. | 13.33 Million USD | -12271.274% |
| Achilles Therapeutics plc | 19.08 Million USD | -8541.809% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -11296.822% |
| 180 Life Sciences Corp. | 5.38 Million USD | -30518.118% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -6892.804% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -7147.282% |
| Nutriband Inc. | 1.07 Million USD | -152780.986% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -5290.751% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -11266.977% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -311.056% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -4979.488% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -12540.431% |
| Palisade Bio, Inc. | 2.73 Million USD | -60121.322% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -31300.381% |
| Beam Therapeutics Inc. | 478.38 Million USD | -244.798% |
| Neurogene Inc. | 36.54 Million USD | -4413.015% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -314.489% |
| AEON Biopharma, Inc. | 159.88 Million USD | -931.629% |
| Sesen Bio, Inc. | 30.98 Million USD | -5223.593% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -6253.615% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -21597.121% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -742.689% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -758.84% |
| Athira Pharma, Inc. | 30.05 Million USD | -5387.78% |
| Vaccinex, Inc. | 5.94 Million USD | -27659.374% |
| HCW Biologics Inc. | 15.05 Million USD | -10858.466% |
| XOMA Corporation | 145.58 Million USD | -1033.028% |
| Nektar Therapeutics | 267.04 Million USD | -517.67% |
| Arvinas, Inc. | 644.6 Million USD | -155.889% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -9201.584% |
| Merus N.V. | 102.15 Million USD | -1514.729% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1027.067% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1634.085% |
| Rezolute, Inc. | 11.73 Million USD | -13957.116% |
| Clene Inc. | 38.95 Million USD | -4134.71% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -57829.114% |
| BeyondSpring Inc. | 48.26 Million USD | -3317.228% |
| Synlogic, Inc. | 32.89 Million USD | -4914.324% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -11187.634% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -100846.267% |
| Peak Bio, Inc. | 20.75 Million USD | -7847.926% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2499.256% |
| Krystal Biotech, Inc. | 39.71 Million USD | -4053.351% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -337.937% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1556.602% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -381079.314% |
| MannKind Corporation | 721.36 Million USD | -128.658% |
| Ikena Oncology, Inc. | 22.33 Million USD | -7285.1% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -78972.963% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1507.819% |
| Gossamer Bio, Inc. | 249.14 Million USD | -562.044% |
| CohBar, Inc. | 1.03 Million USD | -159478.305% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -15331.397% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8559.502% |
| Legend Biotech Corporation | 589.93 Million USD | -179.602% |
| Mural Oncology plc | 37.92 Million USD | -4248.93% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1143.601% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -71761.587% |
| Disc Medicine, Inc. | 22.87 Million USD | -7110.763% |
| Champions Oncology, Inc. | 28.03 Million USD | -5783.581% |
| REGENXBIO Inc. | 262.22 Million USD | -529.018% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -49000.6% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -13059.901% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -12180.433% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -7678.647% |
| Vaxart, Inc. | 34.02 Million USD | -4747.794% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -7989.856% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -5681.119% |
| Cellectis S.A. | 249.57 Million USD | -560.908% |
| Longeveron Inc. | 5.33 Million USD | -30806.165% |
| Repare Therapeutics Inc. | 41.81 Million USD | -3844.288% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 31.422% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -2632.345% |
| Revolution Medicines, Inc. | 262.39 Million USD | -528.613% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -78184.86% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -19021.98% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -13877.307% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -11645.795% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -76583.496% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 67.97% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1241.43% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -29540.493% |
| Veru Inc. | 32.81 Million USD | -4926.9% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -23913.131% |
| Cingulate Inc. | 10.36 Million USD | -15820.119% |
| Passage Bio, Inc. | 39.26 Million USD | -4101.167% |
| Context Therapeutics Inc. | 4.19 Million USD | -39250.528% |
| Exicure, Inc. | 8.54 Million USD | -19194.21% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -5489.881% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -15630.135% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -7383.608% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -912.027% |
| Nuvalent, Inc. | 31.82 Million USD | -5083.239% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -25828.304% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2517.28% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -9063.678% |
| OmniAb, Inc. | 87.4 Million USD | -1787.256% |
| Anew Medical, Inc. | 8.24 Million USD | -19913.373% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -4207.916% |
| Lipocine Inc. | 2.63 Million USD | -62578.364% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -6178.403% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -4001.915% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6091.253% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1814.551% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -30439.937% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1893.38% |
| Ocugen, Inc. | 23.98 Million USD | -6777.63% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3454.339% |
| Q32 Bio Inc. | 233.12 Million USD | -607.535% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -18093.933% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2982.991% |
| Equillium, Inc. | 27.95 Million USD | -5799.996% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -698.415% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -29215.092% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -26795.004% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -948.436% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2275.617% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -16437.285% |
| Dominari Holdings Inc. | 4.63 Million USD | -35487.098% |
| Edesa Biotech, Inc. | 1.84 Million USD | -89464.99% |
| vTv Therapeutics Inc. | 29.56 Million USD | -5478.726% |
| Bio-Techne Corporation | 744.34 Million USD | -121.601% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1208.069% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -378.86% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -3965.217% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -5596.246% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1685.905% |
| Nkarta, Inc. | 105.6 Million USD | -1461.991% |
| BioCardia, Inc. | 4.59 Million USD | -35835.991% |
| Iterum Therapeutics plc | 32.66 Million USD | -4950.095% |